List your tool

Head to head · 2026

OpenEvidence vs Tandem Health

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

OpenEvidence

Used by 40% of US physicians, doubling its valuation to $12B in under a year

4.4Free

Visit OpenEvidence (opens OpenEvidence in a new tab)

Tandem Health

Swedish AI medical scribe and prescription assistant that reached a $1B valuation from Northzone backing

4.0$133/mo

Visit Tandem Health (opens Tandem Health in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: OpenEvidence does not list a price

  • Free plan

    Tie

    Both have one

  • Higher rating

    OpenEvidence

    4.4 against 4.0

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onOpenEvidenceTandem Health
Our rating4.4Better4.0
Starts atFree$133/mo
Free planYesYes
CategoryHealthcare AIHealthcare AI
PlansFreeFrom $133/mo
Key features
  • Point-of-care clinical answers grounded in peer-reviewed literature with citations
  • 760,000 registered US physicians, roughly 40% of all US doctors
  • Approximately 18 million clinical consultations handled monthly
  • Free for verified physicians, monetized through pharmaceutical advertising
  • $12B valuation after a $250M Series D in January 2026
  • AI medical scribe that handles clinical documentation during patient visits
  • AI-assisted prescription workflow support for physicians
  • Free trial available before subscription pricing begins
  • Reached a $1 billion valuation backed by Northzone
  • No setup costs or yearly lock-in contracts
Pros
  • Free access for physicians removes cost as a barrier to point-of-care use
  • Citations grounded in peer-reviewed literature build clinical trust
  • Extraordinarily fast physician adoption validates genuine day-to-day utility
  • Free trial lets a practice test real documentation-time savings before committing
  • No setup costs or lock-in contracts lower the barrier to trying it
  • Strong backing and valuation growth signal real clinical adoption, not just hype
Cons
  • Monetized through pharmaceutical advertising, which some clinicians may view with caution
  • Built for point-of-care physician use, not a full clinical documentation platform
  • Extremely fast valuation growth invites scrutiny over long-term sustainability
  • Primarily built around European healthcare workflows and regulatory context
  • Subscription cost adds up per user across a larger multi-physician practice
  • Ambient scribe accuracy still requires physician review before finalizing notes
CompanyOpenEvidence, founded 2022Tandem Health, founded 2023

Prices come from each vendor's pricing page, last checked 20260716. Check the vendor before you buy.

FAQ

Questions people ask

Is OpenEvidence better than Tandem Health?

In our reviews OpenEvidence scores 4.4 and Tandem Health scores 4.0. The better pick depends on the job. OpenEvidence: Used by 40% of US physicians, doubling its valuation to $12B in under a year. Tandem Health: Swedish AI medical scribe and prescription assistant that reached a $1B valuation from Northzone backing.

Which is cheaper, OpenEvidence or Tandem Health?

OpenEvidence: free. Tandem Health: from $133/mo.

Do OpenEvidence and Tandem Health have free plans?

Yes, both have a free plan.

More comparisons